Th17 is a critical pro-inflammatory mediator in RA that releases IL-17 pro-inflammatory factors to promote inflammation, which preferentially uses glycolysis and glutamine catabolism to provide energy (42). Here, IL17A is linked to rheumatoid arthritis.